IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TRV GP IV, LLC

Q2 2026 Holdings

Filed 2026-08-10 | 2 holdings | $253.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Maze Therapeutics, Inc.(MAZE)COM578784100$133.5M4,473,95852.6%
Tango Therapeutics, Inc.(TNGX)COM87583X109$120.2M6,374,57447.4%